Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Nicox’s Partner Kowa Initiates NCX 470 Phase 3 Clinical Trial in Japan

August 5, 2025

View Press Release Corporate presentation Contact us
Previous